Phyllis Gardner

Biography

 Dr. Gardner has spent more than 30 years in academia, medicine and industry. She began her academic medical career in 1984 at Stanford University, where she has held several positions including Senior Associate Dean for Education and Student Affairs and remains today as Professor of Medicine (with tenure). From 1994 to 1998, she took a leave of absence from Stanford to work at ALZA Corporation (acquired by Johnson & Johnson), a major drug delivery company, as a Principal Scientist, Vice President of Research and as Head of ALZA Technology Institute.   Dr. Gardner also worked with Essex Woodlands from 1999 until 2014, where her expertise in pharmacology and drug delivery was invaluable to the firm in evaluating technology in this growing segment of the pharmaceutical sector. She has received numerous national awards and honors and serves on the Board of Directors of Revance Therapeutics, Inc. as well as the Harvard Medical School Board of Fellows. Dr. Gardner previously served on the Board of Directors of Parnell Pharmaceuticals Holdings Ltd, Aerogen Inc. (acquired by Nektar Pharmaceuticals), and BioMarin Pharmaceuticals, as well as numerous private company boards.   Dr. Gardner holds a B.S. from the University of Illinois, where she graduated Bronze Tablet, Phi Beta Kappa and Phi Kappa Phi, and an M.D. from Harvard Medical School, where she graduated Alpha Omega Alpha. She trained in internal medicine at Massachusetts General Hospital, followed by a Chief Residency at Stanford University Medical Center. Dr. Gardner completed research fellowships at the College of Physicians and Surgeons at Columbia University and University College, London, U.K

Research Interest

 Medicine,Pharmacology and Drug Delivery